» Articles » PMID: 7620165

Role of Accessory Cells in Cytokine Production by T Cells in Chronic B-cell Lymphocytic Leukemia

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1995 Aug 1
PMID 7620165
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the production of cytokines by highly purified T helper cells from B-cell chronic lymphocytic leukemia (B-CLL) patients stimulated by different activation pathways, and we studied the influence of various accessory cell populations on the pattern of the secretion of cytokines, including interleukin (IL)-2, IL-4, interferon-gamma (IFN-gamma), and IL-10. Neither a qualitative nor a quantitative difference in cytokine production and proliferative capacity was observed in CLL-derived purified T cells compared with normal individuals, when T cells were stimulated by different pathways, including CD3, CD2, and costimulation with CD28. Addition of autologous accessory cells (aAC), however, dramatically influenced the cytokine pattern of normal versus B-CLL-derived T cells. CLL cells as aAC caused a marked increase of IL-2, whereas IFN-gamma was only slightly induced and IL-4 was not influenced. In contrast, in normal individuals addition of aAC, which predominantly consisted of monocytes, resulted in a significant increase of IFN-gamma and a reduction of IL-4 secretion. IL-2 production was inhibited by higher concentrations of aAC. The increased stimulation of IL-2 production by CLL cells was not specific to the leukemic cell population, as purified B cells from normal individuals had the same effect. On the other hand, purified monocytes from CLL patients and controls both induced IFN-gamma production and inhibited IL-4 secretion. After antigen-specific stimulation with tetanus toxoid, cytokine secretion was influenced by the type of aAC in a similar pattern. We conclude that T helper cells derived from patients with B-CLL are intrinsically normal and that the predominance of B cells as accessory cells in CLL significantly alters the immune function of T helper cells in vitro.

Citing Articles

T-cell dysfunction in CLL is mediated through expression of Siglec-10 ligands CD24 and CD52 on CLL cells.

van Bruggen J, Peters F, Mes M, Rietveld J, Cerretani E, Cretenet G Blood Adv. 2024; 8(17):4633-4646.

PMID: 39042920 PMC: 11401197. DOI: 10.1182/bloodadvances.2023011934.


Immune defects in patients with chronic lymphocytic leukemia.

Ravandi F, OBrien S Cancer Immunol Immunother. 2005; 55(2):197-209.

PMID: 16025268 PMC: 11029864. DOI: 10.1007/s00262-005-0015-8.


New aspects on the pathogenesis, diagnostic procedures, and therapeutic management of chronic lymphocytic leukemia.

Wendtner C, Schmitt B, Bergmann M, Rohnisch T, Buhmann R, Hallek M Int J Hematol. 2001; 73(1):32-8.

PMID: 11372752 DOI: 10.1007/BF02981900.


Cytokine expression in B-CLL in relation to disease progression and in vitro activation.

Aguilar-Santelises M, Gigliotti D, Osorio L, Santiago A, Mellstedt H, Jondal M Med Oncol. 2000; 16(4):289-95.

PMID: 10618692 DOI: 10.1007/BF02785875.